Open Health
Deep Dive/ Digital/ Views & Analysis/ Views and analysis
Germany’s digital health changes will boost digital therapeutics in Europe
mike.hammerton@pharmaphorum.com
Deep Dive, digital health, Digital Health Innovation 2020, Europe, Open Health, therapeutics
0 Comment
Deep Dive/ Digital/ Views & Analysis/ Views and analysis
Responding to dynamic shifts in value communications
mike.hammerton@pharmaphorum.com
Annemarie Clegg, Beth Lesher, communications, Deep Dive, Deep Dive: Communications 2020, Open Health
0 Comment
Deep Dive/ Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis
Deep Dive: Communications 2020
mike.hammerton@pharmaphorum.com
comms, COVID-19, Deep Dive, EPG Health, HCA, ICON, impetus, Medscape, Open Health, WEGO Health
0 Comment
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
Commercialising innovative new medicines
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive The Future of Oncology, Dorinda Hickey, Innovation, Marja Hensen, Open Health, Rosemary Jose
0 Comment
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
Helping HCPs navigate the ever-evolving advanced cancer landscape
mike.hammerton@pharmaphorum.com
Annie Rankin, asco, cancer, Christine Drewienkiewicz, Deep Dive, Deep Dive The Future of Oncology, HCP, Oncology, Open Health, patient, Sara Black
0 Comment
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
Breaking barriers to patient access in rare oncology
mike.hammerton@pharmaphorum.com
Oncology, Open Health, OPEN VIE, orphan diseases, patient
0 Comment
Jeff Anderson joins OPEN Health in European lead role
Dominic Tyer
comms, market access, Open Health, pharmerit international
0 Comment